These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 29257154)

  • 1. [The post-treatment cognitive impairment ("chemobrain") in breast cancer patients. Short review.].
    Nagykálnai T; Landherr L
    Magy Onkol; 2017 Dec; 61(4):349-351. PubMed ID: 29257154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Chemobrain' in breast carcinoma?: a prologue.
    Wefel JS; Lenzi R; Theriault R; Buzdar AU; Cruickshank S; Meyers CA
    Cancer; 2004 Aug; 101(3):466-75. PubMed ID: 15274059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
    Park JH; Bae SH; Jung YS; Jung YM
    J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of surgical and adjuvant therapies for breast cancer on sexuality, cognitive functions, and body weight.
    Biglia N; Moggio G; Peano E; Sgandurra P; Ponzone R; Nappi RE; Sismondi P
    J Sex Med; 2010 May; 7(5):1891-900. PubMed ID: 20233281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Adjuvant Anthracycline-Based and Taxane-Based Chemotherapy on Plasma VEGF Levels and Cognitive Function in Breast Cancer Patients: A Longitudinal Study.
    Ng T; Phey XY; Yeo HL; Shwe M; Gan YX; Ng R; Ho HK; Chan A
    Clin Breast Cancer; 2018 Oct; 18(5):e927-e937. PubMed ID: 29705024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying a conceptual model for examining health-related quality of life in long-term breast cancer survivors: CALGB study 79804.
    Paskett ED; Herndon JE; Day JM; Stark NN; Winer EP; Grubbs SS; Pavy MD; Shapiro CL; List MA; Hensley ML; Naughton MA; Kornblith AB; Habin KR; Fleming GF; Bittoni MA;
    Psychooncology; 2008 Nov; 17(11):1108-20. PubMed ID: 18314912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine treatment-associated cognitive impairment in breast cancer survivors: evidence from published studies.
    Lee PE; Tierney MC; Wu W; Pritchard KI; Rochon PA
    Breast Cancer Res Treat; 2016 Aug; 158(3):407-20. PubMed ID: 27432418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and late onset cognitive dysfunction associated with chemotherapy in women with breast cancer.
    Wefel JS; Saleeba AK; Buzdar AU; Meyers CA
    Cancer; 2010 Jul; 116(14):3348-56. PubMed ID: 20564075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of videoconference-delivered cognitive behavioral therapy for survivors of breast cancer with self-reported cognitive dysfunction.
    Ferguson RJ; Sigmon ST; Pritchard AJ; LaBrie SL; Goetze RE; Fink CM; Garrett AM
    Cancer; 2016 Jun; 122(11):1782-91. PubMed ID: 27135464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma.
    Schagen SB; van Dam FS; Muller MJ; Boogerd W; Lindeboom J; Bruning PF
    Cancer; 1999 Feb; 85(3):640-50. PubMed ID: 10091737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of changes in perceived attentional function on postsurgical health-related quality of life in breast cancer patients awaiting adjuvant treatment.
    Jung MS; Visovatti MA; Sohn EH; Yoo HS; Kim M; Kim JR; Lee JS
    Health Qual Life Outcomes; 2020 Jul; 18(1):230. PubMed ID: 32664976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy.
    Mehnert A; Scherwath A; Schirmer L; Schleimer B; Petersen C; Schulz-Kindermann F; Zander AR; Koch U
    Patient Educ Couns; 2007 Apr; 66(1):108-18. PubMed ID: 17320337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aerobic exercise on cancer-associated cognitive impairment: A proof-of-concept RCT.
    Campbell KL; Kam JWY; Neil-Sztramko SE; Liu Ambrose T; Handy TC; Lim HJ; Hayden S; Hsu L; Kirkham AA; Gotay CC; McKenzie DC; Boyd LA
    Psychooncology; 2018 Jan; 27(1):53-60. PubMed ID: 28075038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy-induced cognitive impairment in women with breast cancer: a critique of the literature.
    Jansen CE; Miaskowski C; Dodd M; Dowling G
    Oncol Nurs Forum; 2005 Mar; 32(2):329-42. PubMed ID: 15759070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
    Tchen N; Juffs HG; Downie FP; Yi QL; Hu H; Chemerynsky I; Clemons M; Crump M; Goss PE; Warr D; Tweedale ME; Tannock IF
    J Clin Oncol; 2003 Nov; 21(22):4175-83. PubMed ID: 14615445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for breast cancer and cognitive impairment.
    Marín AP; Sánchez AR; Arranz EE; Auñón PZ; Barón MG
    South Med J; 2009 Sep; 102(9):929-34. PubMed ID: 19668023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer chemotherapy-related cognitive dysfunction.
    Ahles TA; Saykin AJ
    Clin Breast Cancer; 2002 Dec; 3 Suppl 3():S84-90. PubMed ID: 12533268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.